Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)

PURPOSE: In addition to mutated BCR-ABL1 kinase, the organic cation transporter 1 (OCT1, encoded by SLC22A1) has been considered to contribute to imatinib resistance in patients with chronic myeloid leukemia (CML). Since data are conflicting as to whether OCT1 transports imatinib and may serve as cl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nies, Anne T., Schaeffeler, Elke, van der Kuip, Heiko, Cascorbi, Ingolf, Bruhn, Oliver, Kneba, Michael, Pott, Christiane, Hofmann, Ute, Volk, Christopher, Hu, Shuiying, Baker, Sharyn D., Sparreboom, Alex, Ruth, Peter, Koepsell, Hermann, Schwab, Matthias
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3932302/
https://ncbi.nlm.nih.gov/pubmed/24352644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1999
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi